Medicenna Therapeutics Corp saw a notable increase in its stock price yesterday, reflecting positive investor sentiment.
Shares of Medicenna Therapeutics Corp (MDNA.TO) climbed by 3.45% in yesterday's trading session, closing at CA$0.45. This upward movement suggests growing confidence among investors in the company's future prospects.
Investor takeaway: Investors are encouraged by Medicenna's recent developments and shareholder support, which may signal a positive trajectory for the company.
Advertisement
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$41.54M
52W high
$1.97
52W low
$0.34
1W change
+16.88%
Beta
2.10
Analyst Price Targets
Based on analyst covering MDNA · as of Sep 17, 2026
Wall Street analysts forecast MDNA stock price to rise 611.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+611.1% Upside
Current Price
C$0.45
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
46.5%
Annualized
90-Day Vol
52.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.54
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.48 | C$0.41 – C$0.56 |
| 60 trading days | C$0.51 | C$0.40 – C$0.64 |
| 90 trading days | C$0.54 | C$0.41 – C$0.71 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
3.45% Increase in Stock Price
Medicenna's stock price increased to CA$0.45, reflecting a positive shift in market sentiment.
Bull case
The recent approval of all director nominees with over 97% shareholder support shows strong governance and investor confidence. This backing could lead to strategic initiatives that enhance shareholder value.
Bear case
Despite the positive movement, Medicenna's lack of profitability and the absence of recent major news might raise concerns about whether this momentum can be sustained.
Advertisement
Positive Investor Sentiment
The increase in Medicenna's stock price can be attributed to a positive shift in investor sentiment, especially after the recent annual general meeting where all director nominees were elected with overwhelming support. This strong backing from shareholders is often seen as a vote of confidence in the company's leadership and strategic direction.
Market Performance and Future Outlook
With a market cap of approximately CA$41.54 million, Medicenna's recent performance may suggest renewed interest from investors. However, it's essential to consider the company's current financial status, as it has yet to report profitability. Investors should monitor upcoming presentations and financial disclosures for insights into future growth potential. For more details, check out the latest updates on Medicenna's stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
